Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes

被引：2
|
作者：
Mendoza, Hadrian [1 ]
Siddon, Alexa J. [2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Dept Internal Med, POB 208030, New Haven, CT 06520 USA
[2] Yale Sch Med, Dept Lab Med, New Haven, CT USA
[3] Yale Sch Med, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, Dept Lab Med, 330 Cedar St,POB 208035, New Haven, CT 06520 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2023年 / 43卷 / 04期
关键词：
Mutations; Myelodysplastic syndromes; Myelodysplasia; Next-generation sequencing; Whole-genome sequencing; ACUTE MYELOID-LEUKEMIA; BIOLOGICAL IMPLICATIONS; COHESIN COMPLEX; WHOLE GENOME; RISK; CLASSIFICATION; POPULATION; LANDSCAPE; EVOLUTION; VARIANTS;
D O I：
10.1016/j.cll.2023.06.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：549 / 563
页数：15
相关论文
共 50 条
  • [31] Prevalence of hemochromatosis gene (HFE) mutations in Greek patients with myelodysplastic syndromes (MDS).
    Speletas, M
    Vlachaki, E
    Papaioannou, G
    Tzoanopoulos, D
    Vasilikioti, S
    Mandala, E
    Ritis, K
    Kartalis, G
    Korantzis, I
    BLOOD, 2001, 98 (11) : 276B - 276B
  • [32] Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
    Nikoloski, Gorica
    Langemeijer, Saskia M. C.
    Kuiper, Roland P.
    Knops, Ruth
    Massop, Marion
    Tonnissen, Evelyn R. L. T. M.
    van der Heijden, Adrian
    Scheele, Theresia N.
    Vandenberghe, Peter
    de Witte, Theo
    van der Reijden, Bert A.
    Jansen, Joop H.
    NATURE GENETICS, 2010, 42 (08) : 665 - 667
  • [33] Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy
    Follo, Matilde Y.
    Pellagatti, Andrea
    Armstrong, Richard N.
    Ratti, Stefano
    Mongiorgi, Sara
    Astolfi, Annalisa
    Indio, Valentina
    Clissa, Cristina
    Russo, Domenico
    Gobbi, Marco
    Barraco, Marilena
    Parisi, Sarah
    Pession, Andrea
    Cavo, Michele
    Manzoli, Lucia
    Cocco, Lucio
    Boultwood, Jacqueline
    Finelli, Carlo
    BLOOD, 2017, 130
  • [34] Degree of Aberrant Antigen Expression in Myelodysplastic Syndromes Correlates with the Number of Molecular Mutations
    Kern, Wolfgang
    Meggendorfer, Manja
    Ogawa, Seishi
    Haferlach, Claudia
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2015, 126 (23)
  • [35] Analysis of flt3 gene mutations and expression in myelodysplastic syndromes (MDS).
    Papageorgiou, S
    Pappa, V
    Economopoulos, T
    Papageorgiou, E
    Dervenoulas, J
    Mantzios, G
    Kontsioti, F
    Valsami, S
    Raptis, S
    BLOOD, 2001, 98 (11) : 355A - 356A
  • [36] Molecular genetics in myelodysplastic syndromes
    Haferlach, Torsten
    LEUKEMIA RESEARCH, 2012, 36 (12) : 1459 - 1462
  • [37] Molecular Biology of Myelodysplastic Syndromes
    Shih, Alan H.
    Levine, Ross L.
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 613 - 620
  • [38] The molecular pathogenesis of the myelodysplastic syndromes
    Pellagatti, Andrea
    Boultwood, Jacqueline
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) : 3 - 15
  • [39] A molecular target for myelodysplastic syndromes
    Man Tsuey Tse
    Nature Reviews Drug Discovery, 2013, 12 : 665 - 665
  • [40] Molecular Pathogenesis of Myelodysplastic Syndromes
    Visconte, Valeria
    Selleri, Carmine
    Maciejewski, Jaroslaw P.
    Tiu, Ramon V.
    TRANSLATIONAL MEDICINE AT UNISA, 2014, 8 : 19 - 30
12345